Camilla N. S. Oliveira

ORCID: 0000-0002-0009-2481
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Inflammation biomarkers and pathways
  • Pharmacological Receptor Mechanisms and Effects
  • Inflammasome and immune disorders
  • COVID-19 Impact on Reproduction
  • Cannabis and Cannabinoid Research
  • Sphingolipid Metabolism and Signaling
  • Long-Term Effects of COVID-19
  • Inflammatory Bowel Disease
  • S100 Proteins and Annexins
  • Ectopic Pregnancy Diagnosis and Management
  • Lipid Membrane Structure and Behavior
  • SARS-CoV-2 and COVID-19 Research
  • Macrophage Migration Inhibitory Factor
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Diabetes and associated disorders
  • Gut microbiota and health
  • Microscopic Colitis
  • COVID-19 Prevention and Impact
  • Metabolomics and Mass Spectrometry Studies
  • Reproductive System and Pregnancy
  • Clostridium difficile and Clostridium perfringens research

Universidade de São Paulo
2020-2023

Universidade de Ribeirão Preto
2020-2023

Patients with COVID-19 predominantly have a respiratory tract infection and acute lung failure is the most severe complication. While molecular basis of SARS-CoV-2 immunopathology still unknown, it well established that associated hyper-inflammation tissue damage. Matrix metalloproteinases (MMPs) contribute to destruction in many pathological situations, activity MMPs leads release bioactive mediators inflammatory properties. We sought characterize scenario which could influence pathogenesis...

10.3390/biom12050604 article EN cc-by Biomolecules 2022-04-19

Uncontrolled inflammatory responses play a critical role in coronavirus disease (COVID-19). In this context, because the triggering-receptor expressed on myeloid cells-1 (TREM-1) is considered an intrinsic amplifier of signals, study investigated soluble TREM-1 (sTREM-1) as biomarker severity and mortality COVID-19. Based their clinical scores, we enrolled COVID-19 positive patients (

10.3390/v13122521 article EN cc-by Viruses 2021-12-15

Lipid and cholinergic mediators are inflammatory regulators, but their role in the immunopathology of COVID-19 is still unclear. Here, we used human blood tracheal aspirate (TA) to investigate whether acetylcholine (Ach), fatty acids (FAs), derived lipid (LMs) associated with severity. First, analyzed perturbation profile induced by SARS-CoV-2 infection transcriptional genes related ACh FA/LM pathways. Blood TA were for metabolomic lipidomic analyses quantification leukocytes, cytokines,...

10.4049/jimmunol.2200079 article EN The Journal of Immunology 2022-07-14

COVID-19 is associated with a dysregulated immune response. Currently, several medicines are licensed for the treatment of this disease. Due to their significant role in inhibiting pro-inflammatory cytokines and lipid mediators, glucocorticoids (GCs) have attracted great deal attention. Similarly, endocannabinoid (eCB) system regulates various physiological processes including immunological Additionally, during inflammatory thrombotic processes, phospholipids from cell membranes cleaved...

10.3390/v15020573 article EN cc-by Viruses 2023-02-19

The non-classical histocompatibility antigen G (HLA-G) is an immune checkpoint molecule that has been implicated in viral disorders. We evaluated the plasma soluble HLA-G (sHLA-G) 239 individuals, arranged COVID-19 patients (n = 189) followed up at home or a hospital, and healthy controls 50). Increased levels of sHLA-G were observed irrespective facility care, gender, age, presence comorbidities. Compared with controls, increased as far disease severity progressed; however, decreased...

10.3390/ijms23179736 article EN International Journal of Molecular Sciences 2022-08-27

SARS-CoV-2 infection triggers distinct patterns of disease development characterized by significant alterations in host regulatory responses. Severe cases exhibit profound lung inflammation and systemic repercussions. Remarkably, critically ill patients display a "lipid storm", influencing the inflammatory process tissue damage. Sphingolipids (SLs) play pivotal roles various cellular processes, including inflammation, metabolic disorders, cancer. In this study, we employed high-resolution...

10.3390/cells12151938 article EN cc-by Cells 2023-07-26

Abstract Cytokine storms and hyperinflammation, potentially controlled by glucocorticoids, occur in COVID-19; the roles of lipid mediators acetylcholine (ACh) how glucocorticoid therapy affects their release Covid-19 remain unclear. Blood bronchoalveolar lavage (BAL) samples from SARS-CoV-2- non-SARS-CoV-2-infected subjects were collected for metabolomic/lipidomic, cytokines, soluble CD14 (sCD14), ACh, CD36-expressing monocyte/macrophage subpopulation analyses. Transcriptome reanalysis...

10.1101/2021.01.07.20248970 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2021-01-09

Abstract Background The uncontrolled inflammatory response plays a critical role in the novel coronavirus disease (COVID-19) and triggering receptor expressed on myeloid cells-1 (TREM-1) is thought to be intricate signal amplification. This study aims investigate association between soluble TREM-1 (sTREM-1) COVID-19 as prognostic biomarker predict severity, lethality clinical management. Methods We enrolled 91 patients with domiciliary care (44 patients) or hospital (47 patients), who were...

10.1101/2020.09.22.20199703 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-09-23

SARS-CoV-2 infection triggers distinct patterns of disease development, characterized by significant alterations in host regulatory responses. Severe cases exhibit profound lung inflammation and systemic repercussions. Remarkably, critically ill patients display a "lipid storm", influencing the inflammatory process tissue damage. Sphingolipids (SL) play pivotal roles various cellular processes, including inflammation, metabolic disorders, cancer. In this study, we employed...

10.20944/preprints202306.0752.v1 preprint EN 2023-06-12
Coming Soon ...